[Source: Research & Innovation] EU-funded researchers have demonstrated huge potential for treating aggressive brain cancer using actively personalised immunotherapy in a first first-stage clinical trial to test the vaccine's safety.
from EUROPA - Syndicated Research News Feed https://ift.tt/2Vlgp33
via IFTTT
No comments:
Post a Comment